Ivermectin 136Mcg, Pyrantel 114Mg

Verify with FDA CVM →

450 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
450
Total Reports
6
Deaths Reported
130.0%
Death Rate

Active Ingredients

Ivermectin 136Mcg, Pyrantel 114Mg

Administration Routes

OralUnknown

Species Affected

Dog 419
Unknown 29
Human 1
Cat 1

Most Affected Breeds

Crossbred Canine/dog 48
Retriever - Labrador 47
Beagle 45
Unknown 30
Shepherd Dog - German 20
Spaniel - Cocker American 17
Collie - Border 15
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 13
Sheepdog - Shetland 11
Dog (unknown) 11

Most Reported Reactions

INEFFECTIVE, HEARTWORM LARVAE 191
Vomiting 82
Lack of efficacy (endoparasite) - hookworm 62
Lack of efficacy - NOS 59
Diarrhoea 36
INEFFECTIVE, ASCARIDS NOS 35
Drug dose administration interval too long 27
Lethargy (see also Central nervous system depression in 'Neurological') 25
Underfilling, Package 18
Underdose 18
Drug dose omission 16
Uncoded sign 15

Outcome Breakdown

Outcome Unknown
252 (59.9%)
Recovered/Normal
133 (31.6%)
Recovered with Sequela
19 (4.5%)
Ongoing
11 (2.6%)
Died
6 (1.4%)

Data Summary

Metric Value
Total adverse event reports 450
Reports involving death 6
Case-fatality rate (reported events) 130.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin 136Mcg, Pyrantel 114Mg Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 450 adverse event reports referencing Ivermectin 136Mcg, Pyrantel 114Mg, including 6 reports in which the animal died — a 130.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin 136Mcg, Pyrantel 114Mg. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin 136Mcg, Pyrantel 114Mg reports are Dog (419 reports), Unknown (29 reports), Human (1 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (48), Retriever - Labrador (47), Beagle (45) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin 136Mcg, Pyrantel 114Mg are INEFFECTIVE, HEARTWORM LARVAE (191), Vomiting (82), Lack of efficacy (endoparasite) - hookworm (62), Lack of efficacy - NOS (59). Of the 421 reports with a coded outcome, Outcome Unknown is the leading category at 59.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin 136Mcg, Pyrantel 114Mg.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial